---
id: 1028909135650332675
author: 1606183309
published_date: 2018-08-13 07:40:28 +00:00
conversation_id: [[Conversation-1028795983168077824]]
in_reply_to: [[1028906820507557888]]
retweet: None
quoted_tweet: None
---
@eliasbareinboim @yudapearl (2/2) What I am saying is that the Do-Operator is interesting because and only because it corresponds to what would have happened in a hypothetical trial. If those two ever came apart (and I don't think they will), the model-based parameter is no longer interesting.
